NCT05901051View on ClinicalTrials.gov

High-dose Dual Therapy with Different Administration Frequencies

PHASE4CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

September 10, 2023

Study Completion Date

September 30, 2023

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

vonoprazan

Potassium competitive acid blocker

DRUG

Amoxicillin

Antibiotics for H. pylori eradication

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT05901051 - High-dose Dual Therapy with Different Administration Frequencies | Biotech Hunter | Biotech Hunter